FPL-12495
FPL-12495 is a chemical compound that has been studied for its potential pharmacological effects. It is primarily known for its role as a calcium channel blocker, which means it can inhibit the influx of calcium ions through voltage-gated calcium channels in the cell membrane. This action can have various physiological effects, particularly on the cardiovascular system.
Pharmacology[edit | edit source]
FPL-12495 acts by binding to specific sites on the calcium channels, thereby preventing calcium ions from entering the cells. This can lead to a decrease in vascular smooth muscle contraction, resulting in vasodilation and a subsequent reduction in blood pressure. The compound has been of interest in the study of hypertension and other cardiovascular disorders.
Mechanism of Action[edit | edit source]
The mechanism by which FPL-12495 exerts its effects involves the blockade of L-type calcium channels. These channels are crucial for the contraction of cardiac and smooth muscle. By inhibiting these channels, FPL-12495 reduces the contractility of the heart and dilates blood vessels, which can lower blood pressure and decrease the workload on the heart.
Clinical Applications[edit | edit source]
While FPL-12495 has shown promise in preclinical studies, its clinical applications are still under investigation. It is not currently approved for use in humans, but it serves as a valuable tool in research settings to understand the role of calcium channels in various physiological and pathological processes.
Research and Development[edit | edit source]
Research on FPL-12495 has primarily focused on its potential as a therapeutic agent for cardiovascular diseases. Studies have explored its effects on cardiac arrhythmias, angina pectoris, and hypertension. However, further research is needed to fully understand its efficacy and safety profile.
Safety and Toxicology[edit | edit source]
The safety profile of FPL-12495 is not well-established, as it has not undergone extensive clinical testing. Preclinical studies suggest that, like other calcium channel blockers, it may have side effects such as hypotension, dizziness, and bradycardia. Toxicological studies are necessary to determine its potential risks and safe dosage ranges.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
